Skip to end of metadata
Go to start of metadata

You are viewing an old version of this page. View the current version.

Compare with Current View Page History

Version 1 Next »

Question

Concept

What do you want to do?

🔘 Enrol a new client

🔘 Transfer in a client

🔘 Enrol a Mother into PMTCT program

🔘 Re-enrol a client

Enrolment Date

␣␣-␣␣-␣␣␣␣ 📆

Unique ID

__________________________________

Entry Point

__________________________________

Population Category

🔘 General population

🔘 Key population

🔘 Priority population

Key Population Type

🔘 Intravenous drug user

🔘 Male who has sex with men

🔘 Prisoners

🔘 Sex worker

🔘 Transgender Persons

Priority Population Type

🔽

🔽

🔽

🔽

Transfer-In

Transferring Facility

__________________________________

Start ART Date

␣␣-␣␣-␣␣␣␣ 📆

Current ART Regimen

🔽

🔽

🔽

🔽

🔽

Transfer Documents

Transfer Documents

🔘 Mother enrolled in prevention of maternal to child transmission (PMTCT) program

🔘 Transfer-in with Records

🔘 Transfer-in without records

Date of Enrolment into HIV Care

␣␣-␣␣-␣␣␣␣ 📆

HIV Diagnosis

Date Confirmed HIV Positive

␣␣-␣␣-␣␣␣␣ 📆

Test Type

🔘 Rapid test for HIV

🔘 HIV DNA polymerase chain reaction

🔘 Unknown

Test Location

__________________________________

Previous ARV/HAART Use

Use of Pre Exposure Prophylaxis (PrEP)

🔘 Yes

🔘 No

🔘 Unknown

Date Last Used

␣␣-␣␣-␣␣␣␣ 📆

Use of Post-exposure prophylaxis (PEP)

🔘 Yes

🔘 No

🔘 Unknown

Date Last Used

␣␣-␣␣-␣␣␣␣ 📆

ARV Use for Management of Hepatitis

🔘 Yes

🔘 No

🔘 Unknown

Date Last Used

␣␣-␣␣-␣␣␣␣ 📆

ART Use for Prevention of Mother to Child Transmission of HIV

🔘 Yes

🔘 No

🔘 Unknown

Date Last Used

␣␣-␣␣-␣␣␣␣ 📆

Nucleoside Reverse Transcriptase Inhibitors (NRTIS

🔽

🔽

🔽

🔽

🔽

Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIS)

🔽

🔽

🔽

🔽

🔽

Protease Inhibitors (PIS)

🔽

🔽

🔽

🔽

🔽

Other HIV Drug Classes

🔽

🔽

🔽

🔽

🔽

Treatment Supporter

Treatment Supporter Available

🔘 Yes

🔘 No

Treatment Supporter Name

__________________________________

Treatment Supporter Phone Number

__________________________________

Treatment Supporter Relationship

🔽

🔽

🔽

🔽

Re-enrollment

Date of Re-enrollment

␣␣-␣␣-␣␣␣␣ 📆

Reason For Re-enrolment

Test Location

__________________________________

  • No labels